Unlike clonal eosinophilic disorders secondary to PDGFRA and PDGFRB translocations [8], the WHO-defined CEL-NOS entity is not responsive to imatinib mesylate monotherapy. The gene discussed is PDGFRA; the disease is Chronic Eosinophilic Leukemia, Not Otherwise Specified.